Todorova G, Hatton R, Sadique S, Pollick F
Autism. 2023; 28(2):498-509.
PMID: 37294012
PMC: 10851622.
DOI: 10.1177/13623613231176714.
Loth E
Front Psychiatry. 2023; 14:1085445.
PMID: 36911126
PMC: 9992810.
DOI: 10.3389/fpsyt.2023.1085445.
Waizbard-Bartov E, Fein D, Lord C, Amaral D
Autism Res. 2023; 16(4):685-696.
PMID: 36786314
PMC: 10500663.
DOI: 10.1002/aur.2898.
Eigsti I, Fein D
Front Psychiatry. 2022; 13:972612.
PMID: 36051556
PMC: 9424653.
DOI: 10.3389/fpsyt.2022.972612.
Andreou M, Skrimpa V
Brain Sci. 2022; 12(8).
PMID: 36009175
PMC: 9405985.
DOI: 10.3390/brainsci12081113.
ASD-Time for a paradigm shift.
Levy Y
Front Psychiatry. 2022; 13:956351.
PMID: 35935420
PMC: 9354486.
DOI: 10.3389/fpsyt.2022.956351.
Exploring Change in Children's and Art Therapists' Behavior during 'Images of Self', an Art Therapy Program for Children Diagnosed with Autism Spectrum Disorders: A Repeated Case Study Design.
Schweizer C, Knorth E, Van Yperen T, Spreen M
Children (Basel). 2022; 9(7).
PMID: 35884019
PMC: 9316469.
DOI: 10.3390/children9071036.
Rethinking Our Concepts and Assumptions About Autism.
Lombardo M, Mandelli V
Front Psychiatry. 2022; 13:903489.
PMID: 35722549
PMC: 9203718.
DOI: 10.3389/fpsyt.2022.903489.
Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions.
McCracken J, Anagnostou E, Arango C, Dawson G, Farchione T, Mantua V
Eur Neuropsychopharmacol. 2021; 48:3-31.
PMID: 34158222
PMC: 10062405.
DOI: 10.1016/j.euroneuro.2021.05.010.
Prototyping as subtyping strategy for studying heterogeneity in autism.
Lombardo M
Autism Res. 2021; 14(10):2224-2227.
PMID: 34077630
PMC: 8519106.
DOI: 10.1002/aur.2535.
Going Beyond the Catch-22 of Autism Diagnosis and Research. The Moral Implications of (Not) Asking "What Is Autism?".
Bervoets J, Hens K
Front Psychol. 2020; 11:529193.
PMID: 33240143
PMC: 7683513.
DOI: 10.3389/fpsyg.2020.529193.
Parsing Heterogeneity in Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder with Individual Connectome Mapping.
Dajani D, Burrows C, Nebel M, Mostofsky S, Gates K, Uddin L
Brain Connect. 2019; 9(9):673-691.
PMID: 31631690
PMC: 6862970.
DOI: 10.1089/brain.2019.0669.
Big data approaches to decomposing heterogeneity across the autism spectrum.
Lombardo M, Lai M, Baron-Cohen S
Mol Psychiatry. 2019; 24(10):1435-1450.
PMID: 30617272
PMC: 6754748.
DOI: 10.1038/s41380-018-0321-0.
Brain Connectivity and Neuroimaging of Social Networks in Autism.
Muller R, Fishman I
Trends Cogn Sci. 2018; 22(12):1103-1116.
PMID: 30391214
PMC: 7080636.
DOI: 10.1016/j.tics.2018.09.008.
ASD Comorbidity in Fragile X Syndrome: Symptom Profile and Predictors of Symptom Severity in Adolescent and Young Adult Males.
Abbeduto L, Thurman A, McDuffie A, Klusek J, Feigles R, Brown W
J Autism Dev Disord. 2018; 49(3):960-977.
PMID: 30382442
PMC: 6556533.
DOI: 10.1007/s10803-018-3796-2.
Associations between parental broader autism phenotype and child autism spectrum disorder phenotype in the Study to Explore Early Development.
Rubenstein E, Wiggins L, Schieve L, Bradley C, DiGuiseppi C, Moody E
Autism. 2018; 23(2):436-448.
PMID: 29376397
PMC: 6027594.
DOI: 10.1177/1362361317753563.
Homogeneous Subgroups of Young Children with Autism Improve Phenotypic Characterization in the Study to Explore Early Development.
Wiggins L, Tian L, Levy S, Rice C, Lee L, Schieve L
J Autism Dev Disord. 2017; 47(11):3634-3645.
PMID: 28879490
PMC: 5848505.
DOI: 10.1007/s10803-017-3280-4.
Autism: a transdiagnostic, dimensional, construct of reasoning?.
Aggernaes B
Eur J Neurosci. 2017; 47(6):515-533.
PMID: 28452080
PMC: 6084350.
DOI: 10.1111/ejn.13599.
Cerebellar gray matter differentiates children with early language delay in autism.
DMello A, Moore D, Crocetti D, Mostofsky S, Stoodley C
Autism Res. 2016; 9(11):1191-1204.
PMID: 27868392
PMC: 11079618.
DOI: 10.1002/aur.1622.
Perspectives on "Disease" and "Disability" in Child Health: The Case of Childhood Neurodisability.
Miller A, Rosenbaum P
Front Public Health. 2016; 4:226.
PMID: 27833905
PMC: 5080371.
DOI: 10.3389/fpubh.2016.00226.